Bova Aus

What Bova Aus does

Bova Aus is an Australian veterinary compounding pharmacy that creates customised pharmaceutical formulations prescribed by veterinarians for animal patients. Founded by Colin Bova in 1968 as a human pharmacy in Sydney, the business pivoted into veterinary compounding in 2010 under the leadership of his son Nick Bova and now operates from a stand-alone compounding facility in Caringbah, NSW with 66 employees. The company is one of a small number of dedicated veterinary compounding facilities in Australia and is closely associated with the Sweden-listed veterinary health group Vimian through footer-level corporate policy references, while publicly presenting as family-owned.

The company's product platform is built around two core formulation types: Quality Assured (QA) batch-tested compounded medications, which carry same-day or next-day dispatch SLAs and a 10% discount penalty if missed, and Made-to-Order custom-compounded formulations tailored to individual animal needs. Technical capabilities include sterile and cytotoxic laboratory suites with NATA-validated equipment, end-product potency and stability testing, custom dosage forms (liquids, gels, transdermal creams), synthetic allergen-free flavourings, and combination medications. The QA programme is voluntarily aligned with APVMA regulations, European Medicines Agency stability guidelines, and USP/BP pharmacopoeia standards. Adjacent offerings include the Nextmune Pax allergy product distributed under partnership, FIP (Feline Infectious Peritonitis) treatment resources, and the Bova Scholars free online CPD platform for veterinary professionals.

Bova generates revenue through a B2B sales model targeting veterinary clinics across Australia, with prescribing veterinarians placing orders directly through an online portal (bovavet.com.au) or by phone and fax, while pet owners are directed to a phone line. Repeat prescriptions are stored on file to support ongoing refills, and payments are accepted via MasterCard, Visa, Direct Debit, and cheque. Pricing is quote-based and not publicly disclosed, operating on a unit pricing pay-as-you-go cadence. The company presents as a vertical specialist serving a long-tail of Australian veterinary practices with no disclosed enterprise anchor customers.

Name

Bova Aus

Legal name

Bova Aus

Website

https://bovavet.com.au

Company type

Private

Founded year

1968

Operating status

Operating

Headcount range

51–100 employees

Short description

Bova Aus is an Australian veterinary compounding pharmacy serving Australian veterinarians with customised pharmaceutical formulations, including Quality Assured batch-tested products and made-to-order medications in alternative dosage forms.

Ownership category

akta.pro rank

Product category

Veterinary Pharmaceutical Compounding

NAICS

Pharmaceutical Preparation Manufacturing (325412)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Compounding Pharmacies (Veterinary) (HLAMAIAD)

akta.pro secondary industry

Generic & Private-Label Veterinary Pharmaceuticals (HLAMAEAM)

Keywords

• Veterinary compounding pharmacy
• Custom veterinary medications
• Sterile pharmaceutical compounding
• Veterinary pharmaceutical formulations
• Compounding veterinary medicines

Headquarters

HQ city

Caringbah, Sydney

HQ country

Australia

HQ region

Oceania

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Compounded Veterinary Medications: Primary revenue from custom-compounded pharmaceutical formulations for veterinary patients. Orders are placed by prescribing veterinarians, with repeat prescriptions kept on file. Accepts MasterCard, Visa, Direct Debit, and cheque payments.

Pricing tiers

Go-to-market motion1 record

Distribution channels2 records

Marketing channels4 records

Core offering

Bova Aus is a stand-alone veterinary compounding pharmacy that custom-compounds pharmaceutical formulations for animal patients on prescription from veterinarians. The pharmacy produces Quality Assured batch-tested formulations (with same-day/next-day dispatch) and made-to-order compounded medications in customised dosages, alternative forms (liquids, gels, transdermal creams), synthetic flavours, allergen-free formulations, and combination medications. It also compounds specialised sterile and cytotoxic medications for sensitive treatments such as chemotherapy.

Product overview

Bova Aus is a family-owned Australian veterinary compounding pharmacy offering two core formulation types: Quality Assured (batch-tested, same-day/next-day dispatch) and Made-to-Order (custom-compounded). Additional offerings include cytotoxic/sterile medications, the Nextmune Pax allergy product, FIP treatment resources, and the Bova Scholars veterinary education program. All products are supported by an online ordering platform for registered veterinarians.

Differentiator

Problem solved

Functional benefit

Brands

• Quality Assured: Bova's quality assurance program for compounded medications that adhere to APVMA regulations and undergo testing per European Medicines Agency guidelines.

Products and services

• Quality Assured Formulations Batch-tested compounded veterinary medications that undergo end-product testing for potency and stability before release; offered with same-day or next-day dispatch guarantees to prescribing veterinarians across Australia.
• Made-to-Order Compounded Formulations Custom-compounded medications prepared to meet individual animal patient needs, including alternative dosages, alternative forms (liquids, gels, transdermal creams), synthetic flavourings, allergen-free formulations, and combination medications in a single dosage form.
• Cytotoxic and Sterile Compounded Medications Specialised sterile and cytotoxic compounding services for chemotherapy and other sensitive veterinary treatments, produced in dedicated laboratory suites with NATA-validated equipment.

Quantifiable outcome

• 48-hour prescription turnaround (target)
• +2 more outcomes

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature5 records

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

Others

• MEDISCA: Global pharmaceutical compounding supplier providing ingredients, equipment, and training to compounding pharmacies. Connected as an upstream enabler of the veterinary compounding industry Bova operates in.
• Nextmune: Vimian Group subsidiary focused on allergy diagnostics and immunotherapy for animals. Bova already distributes Nextmune Pax; relevant as an ecosystem peer operating in the same veterinary specialty channel under shared ownership.
• Vetio: Animal health contract development and manufacturing organisation (CDMO) within the Vimian Group ecosystem. Adjacent comparator in the animal-health pharmaceutical manufacturing value chain under the same parent group.

Direct peers

• Roadrunner Pharmacy: US veterinary compounding pharmacy focused on customised medications for companion animals. Directly comparable in custom dosage, flavour, and form offerings delivered to veterinary practices.
• BCP Veterinary Pharmacy: UK-based veterinary compounding pharmacy producing tailored medications for veterinary practices. Comparable in offering of custom dosages, flavours, and formulations targeting the same vet-prescriber customer.
• Wedgewood Pharmacy: Largest US veterinary compounding pharmacy, offering custom dosage forms, flavours, and batch-tested preparations to veterinarians. Directly comparable in product category, customer base (vet clinics), and emphasis on quality assurance.
• Stokes Pharmacy: US veterinary and specialty compounding pharmacy serving animal hospitals and veterinarians with customised medications. Comparable in service scope (sterile and non-sterile compounding) and B2B vet-clinic go-to-market.
• Bova UK: Sister business operating the same veterinary compounding model in the United Kingdom under the Bova brand. Directly comparable in product offering (Quality Assured and Made-to-Order formulations), customer base (veterinary clinics), and operational structure under Vimian Group.

Broad incumbents

• Dechra Pharmaceuticals: Global specialty veterinary pharmaceuticals manufacturer with a broad therapeutic portfolio. Comparable as a larger, established veterinary pharma player operating across companion and production animal segments, providing context for where Bova's bespoke offering sits versus commercial products.

Emerging players

• Nexgen Compounding: US veterinary compounding pharmacy serving companion animal practices with customised formulations. Comparable as a niche veterinary compounder focused on tailored dosages and flavours for vet clinic customers.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/bova-compounding

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Bova Aus